Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 2/1/1989


1.		Phase III Trial of ICS 205-930 vs a Metoclopramide-Containing Antiemetic Cocktail for the Prevention of Cisplatin-Induced Emesis in Patients with non-Small Cell Lung Cancer or Cancer of the Head and Neck (Summary Last Modified 02/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				over 18								EORTC-08881


2.		Phase I/II Regional Chemotherapy with CACP/DCM for Advanced Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				UAB-154 NCI-T83-1229D, T83-1229


3.		Phase I/II Comparative Evaluation of Continuous vs Intermittent CACP in Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				15 and over								MDA-DM-8490 NCI-V85-0135

Last Modified: 2/1/1991


4.		Phase I/II Study of Escalating Single Doses of Metoclopramide Given in Combination with Dexamethasone and Lorazepam for the Control of Cisplatin-Induced Nausea and Vomiting (Summary Last Modified 02/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care				Completed				30 and over								MSKCC-88074 NCI-V88-0580

Last Modified: 7/1/1990


5.		Randomized Study of a Triple Antiemetic Combination Suppository Containing Metoclopramide/Dexamethasone/Diphenhydramine for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Summary Last Modified 07/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				18 to 70								UKMC-87GYN03 NCI-V88-0455

Last Modified: 11/1/1992


6.		Evaluation of MDLO (Metoclopramide/Dexamethasone/Lorazepam/Ondansetron) for the Prevention of Acute Vomiting In Cancer Patients Receiving High-Dose Cisplatin (Summary Last Modified 11/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				18 and over								MSKCC-91072 NCI-V91-0180

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute